Pierre Gantner
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 4
- SARS-CoV-2 and COVID-19 Research 3
- Virology 15
- HIV Research and Treatment 15
- Co-authors
- Nicolas Chomont (6 shared papers)Rémi Fromentin (3 shared papers)Samira Fafi‐Kremer (17 shared papers)Caroline Dufour (2 shared papers)Marion Pardons (3 shared papers)Morgane Solis (6 shared papers)Amélie Pagliuzza (4 shared papers)Aurélie Velay (9 shared papers)
- Journals
- PLoS ONE (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)Nature Communications (2 papers)HIV Medicine (2 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
Pierre Gantner
33 papers receiving 511 citations
Peers
Comparison fields: 5 of 55
- Virology 234
- Infectious Diseases 230
- Parasitology 50
- Immunology 100
- Transplantation 12
Countries citing papers authored by Pierre Gantner
This map shows the geographic impact of Pierre Gantner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Gantner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Gantner more than expected).
Fields of papers citing papers by Pierre Gantner
This network shows the impact of papers produced by Pierre Gantner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Gantner. The network helps show where Pierre Gantner may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Gantner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 72 | |
| 2 | 2020 | 58 | |
| 3 | 2021 | 50 | |
| 4 | 2019 | 48 | |
| 5 | 2023 | 46 | |
| 6 | 2017 | 45 | |
| 7 | 2019 | 23 | |
| 8 | 2019 | 21 | |
| 9 | 2015 | 21 | |
| 10 | 2019 | 16 | |
| 11 | 2016 | 13 | |
| 12 | 2014 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2015 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2024 | 7 | |
| 17 | 2024 | 7 | |
| 18 | 2017 | 7 | |
| 19 | 2017 | 7 | |
| 20 | 2018 | 6 |
About Pierre Gantner
Pierre Gantner is a scholar working on Infectious Diseases, Virology, Epidemiology, Immunology and Parasitology, having authored 36 papers that have together received 517 indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (4 papers), Immune Cell Function and Interaction (4 papers), Hepatitis B Virus Studies (3 papers), Vector-borne infectious diseases (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Virology (234 citations), Infectious Diseases (230 citations), Parasitology (50 citations), Immunology (100 citations) and Transplantation (12 citations). Pierre Gantner has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Nicolas Chomont, Rémi Fromentin, Samira Fafi‐Kremer, Caroline Dufour, Marion Pardons, Morgane Solis, Amélie Pagliuzza, Aurélie Velay, Moti Ramgopal and Jean‐Pierre Routy. Their work appears in journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy, Nature Communications, HIV Medicine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.